Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 9(1): 12605, 2019 08 30.
Artigo em Inglês | MEDLINE | ID: mdl-31471537

RESUMO

Aggresomes are inclusion bodies for misfolded/aggregated proteins. Despite the role of misfolded/aggregated proteins in neurological disorders, their role in cancer pathogenesis is poorly defined. In the current study we aimed to investigate whether aggresomes-positivity could be used to improve the disease subclassification and prognosis prediction of pediatric medulloblastoma. Ninety three pediatric medulloblastoma tumor samples were retrospectively stratified into three molecular subgroups; WNT, SHH and non-WNT/non-SHH, using immunohistochemistry and Multiplex Ligation Probe Amplification. Formation of aggresomes were detected using immunohistochemistry. Overall survival (OS) and event-free survival (EFS) were determined according to risk stratification criteria. Multivariate Cox regression analyses were carried out to exclude confounders. Aggresomes formation was detected in 63.4% (n = 59/93) of samples. Aggresomes were non-randomly distributed among different molecular subgroups (P = 0.00002). Multivariate Cox model identified aggresomes' percentage at ≥20% to be significantly correlated with patient outcome in both OS (HR = 3.419; 95% CI, 1.30-8.93; P = 0.01) and EFS (HR = 3; 95% CI, 1.19-7.53; P = 0.02). The presence of aggresomes in ≥20% of the tumor identified poor responders in standard risk patients; OS (P = 0.02) and EFS (P = 0.06), and significantly correlated with poor outcome in non-WNT/non-SHH molecular subgroup; OS (P = 0.0002) and EFS (P = 0.0004).


Assuntos
Proteínas Hedgehog/genética , Meduloblastoma/genética , Agregados Proteicos/genética , Deficiências na Proteostase/genética , Proteínas Wnt/genética , Adolescente , Biomarcadores Tumorais/genética , Criança , Pré-Escolar , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Meduloblastoma/classificação , Meduloblastoma/epidemiologia , Meduloblastoma/patologia , Pediatria , Prognóstico , Deficiências na Proteostase/classificação , Deficiências na Proteostase/epidemiologia , Deficiências na Proteostase/patologia , Estudos Retrospectivos , Fatores de Risco
2.
Mol Biol (Mosk) ; 46(3): 402-15, 2012.
Artigo em Russo | MEDLINE | ID: mdl-22888630

RESUMO

A number of neurodegenerative disorders have recently been coalesced into a group of proteinopathies because of the similarity of molecular mechanisms underlying their pathogenesis. A key step in the development of proteinopathies is a structural change that triggers aggregation of proteins, which are intrinsically prone to form aggregates due to their physical and chemical properties. Present review is devoted to the recent progress in the field of proteinopathies with specific focus on properties of aggregate-prone proteins, main stages of the development of molecular pathology and the role of cellular clearance systems in progression of neurodegeneration. Recent modifications in the nomenclature of neurodegenerative diseases will also be addressed.


Assuntos
Proteínas Amiloidogênicas/química , Doenças Neurodegenerativas/metabolismo , Deficiências na Proteostase/metabolismo , Proteínas Amiloidogênicas/metabolismo , Autofagia , Humanos , Doenças Neurodegenerativas/classificação , Doenças Neurodegenerativas/fisiopatologia , Estresse Oxidativo , Complexo de Endopeptidases do Proteassoma/metabolismo , Conformação Proteica , Dobramento de Proteína , Deficiências na Proteostase/classificação , Deficiências na Proteostase/fisiopatologia , Espécies Reativas de Oxigênio/metabolismo , Terminologia como Assunto , Fatores de Tempo , Ubiquitina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...